12.85

10.89% -1.57

After Hours: 12.30 -0.55 -4.28%

Capsovision Inc (CV)

Overview News Price History Discussions Forecast

Capsovision Inc stock is traded at $12.85, with a volume of 347.20K. It is down -10.89% in the last 24 hours and up +131.95% over the past month. CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. Internal GI imaging facilitates earlier detection of colorectal cancer and other diseases, enabling more timely and effective treatment regimens for patients. The Company's core technology platform is an orally ingestable capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. The Company's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D directed at the large intestines.

Previous Close:

$14.42

Open:

$14.49

24h Volume:

347.20K

Relative Volume:

3.00

Market Cap:

$601.94M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+86.23%

1M Performance:

+131.95%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$12.15

$15.00

1-Week Range:

$6.7327

$15.37

52-Week Range:

$3.4341

$15.37

Capsovision Inc Stock (CV) Company Profile

Name

Capsovision Inc

Sector

Healthcare (1123)

Industry

Medical Devices (141)

Phone

(408) 370-4790

Address

18805 COX AVENUE SUITE 250, SARATOGA

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CV's Discussions on Twitter

Compare CV with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CV Capsovision Inc	12.85	675.48M	0	0	0	0.00
ABT Abbott Laboratories	125.46	214.37B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	92.58	136.01B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	354.09	134.98B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	99.87	127.88B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	83.08	48.88B	5.88B	1.34B	799.60M	2.3489

Capsovision Inc Stock (CV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-28-25	Initiated	Roth Capital	Buy
Jul-28-25	Initiated	The Benchmark Company	Speculative Buy

Capsovision Inc Stock (CV) Latest News

Dec 11, 2025

CapsoVision (NASDAQ: CV) Stock Rockets After-Hours: Price Action, Q3 Earnings and 2026 Outlook - ts2.tech

Dec 11, 2025

Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Dec 11, 2025

Is CapsoVision Showing How Far A Single Capsule Can Take A Med-Tech Company? - RTTNews

Dec 11, 2025

Dec 10, 2025

What Sparked CapsoVision's (CV) 53% Surge In After-Hours Trading? - Benzinga

Dec 10, 2025

A look into CapsoVision Inc (CV)’s deeper side - setenews.com

Dec 10, 2025

Dec 08, 2025

CapsoVision Welcomes David Garcia to its Senior Executive Team - Medical Product Outsourcing

Dec 08, 2025

Dec 05, 2025

CapsoVision (CV) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 05, 2025

Nov 30, 2025

CapsoVision reports Q3 EPS (17c) vs ($2.79) last year - MSN

Nov 30, 2025

Nov 20, 2025

CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference - GlobeNewswire

Nov 20, 2025

CapsoVision (NASDAQ: CV) to Host 1:1 Investor Meetings at Benchmark Discovery Conference - Stock Titan

Nov 20, 2025

Nov 18, 2025

Benchmark reiterates Speculative Buy rating on CapsoVision stock at $5 By Investing.com - Investing.com Australia

Nov 15, 2025

Nov 14, 2025

Benchmark reiterates Speculative Buy rating on CapsoVision stock at $5 - Investing.com

Nov 14, 2025

Nov 13, 2025

CapsoVision Reports Revenue Growth and Strategic Advances - TipRanks

Nov 13, 2025

CapsoVision Q3 2025 Earnings Call Transcript - MarketBeat

Nov 13, 2025

CapsoVision, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 13, 2025